CAPR
Capricor Therapeutics Inc
8.70$
-7.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +95.4% | -59.4% | -19.1% | -43.1% | +392.1% | -100.0% | – | – | – | – | – | – | |
| – | +3,495.4% | +11.7% | +12.6% | -5.6% | +23.3% | +30.0% | +16.6% | -7.7% | – | – | – | – | |
| – | -65.3% | -388.4% | – | – | – | – | – | – | – | – | – | – | |
| – | -0.9% | +11.7% | +12.6% | -5.6% | +23.3% | +30.0% | +16.6% | -7.7% | +13.6% | +18.3% | +5.4% | – | |
| – | +17.9% | +18.7% | -24.9% | +13.3% | +23.4% | +42.0% | -6.5% | +4.5% | -2.5% | +58.3% | +54.0% | – | |
| – | -73.7% | +18.7% | -24.9% | +13.3% | +23.4% | +42.0% | -6.5% | +4.5% | +392.1% | +26.1% | +16.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +100.0% | +25.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -103.4% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.